Pulmonary exacerbations, clinic assessments and hospital admissions over time
| PA infection status (mean (SE)), p value* | No PA n=44 | Transient PA n=29 | Chronic PA (unique) n=137 | Chronic PA (PES) n=64 |
|---|---|---|---|---|
| PEx––IV antibiotic use, days/year | ||||
| Total IV antibiotics | 1.98 (1.46) ref | 1.23 (0.60) p=0.56 | 1.59 (0.36) p=0.76 | 2.88 (0.72) p=0.54 |
| Home IV antibiotics | 0.08 (0.05) ref | 0.08 (0.04) p=1.00 | 0.095 (0.02) p=0.80 | 0.23 (0.07) p=0.08 |
| Inpatient IV antibiotics | 1.51 (1.19) ref | 0.75 (0.39) p=0.55 | 1.18 (0.25) p=0.79 | 2.27 (0.68) p=0.57 |
| Clinic days/year | 3.45 (0.30) ref | 3.73 (0.31) p=0.49 | 4.47 (0.18) p=0.003 | 4.37 (0.19) p=0.008 |
| Hospital admissions/year | 0.28 (0.07) ref | 0.28 (0.10) p=0.97 | 0.48 (0.05) p=0.03 | 0.53 (0.08) p=0.02 |
| Hospital days/year | 2.98 (0.93) ref | 1.86 (1.62) p=0.36 | 5.97 (1.66) p=0.047 | 6.80 (1.91) p=0.03 |
*p Values calculated in comparison with the reference group (no PA group)—1.00.
IV, intravenous; PA, P. aeruginosa; PES, Prairie Epidemic Strain; PEx, pulmonary exacerbation.